AAKAAR — Aakaar Medical Technologies Income Statement
0.000.00%
- IN₹1.08bn
- IN₹1.23bn
- IN₹461.11m
Annual income statement for Aakaar Medical Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 195 | 328 | 461 |
| Cost of Revenue | |||
| Gross Profit | 104 | 178 | 252 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 171 | 293 | 412 |
| Operating Profit | 23.7 | 34.4 | 48.6 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 22 | 31 | 38.9 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 16.2 | 21.5 | 28.7 |
| Net Income Before Extraordinary Items | |||
| Net Income | 16.2 | 21.5 | 28.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 16.2 | 21.5 | 28.7 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 1.14 | 1.52 | 2.03 |